Meng FY - Search Results

1

[Overview of chronic myelogenous leukemia and its current diagnosis and treatment patterns in 15 hospitals in China.].

Wang JX, Huang XJ, Wu DP, Hu JD, Liu T, Hu Y, Meng FY, Chen XQ, Hou M, Li Y, Wang SJ, Wang JM, Ren HY, Yu L, Chen FY, Qiu LG, Jiang B, Sun AN, Liu TB, Zhu HL, Guo T, Xu D, Ji CY, Lü XY, Jiao L, Song XM, Huang HH. Wang JX, et al. Among authors: meng fy. Zhonghua Xue Ye Xue Za Zhi. 2009 Nov;30(11):721-5. Zhonghua Xue Ye Xue Za Zhi. 2009. PMID: 20137304 Review. Chinese.

2

[Expression of vascular endothelial growth factor in bone marrow cells of patients with acute myeloid leukemia].

Xu D, Meng FY, Zhang Y. Xu D, et al. Among authors: meng fy. Di Yi Jun Yi Da Xue Xue Bao. 2002 Apr;22(4):357-9. Di Yi Jun Yi Da Xue Xue Bao. 2002. PMID: 12422902 Chinese.

3

[The application of dual fusion interphase fluorescence in situ hybridization probe in detecting minimal residual disease in chronic myeloid leukemia].

Du Q, Liu X, Song L, Meng F, Zhou S. Du Q, et al. Zhonghua Nei Ke Za Zhi. 2002 Dec;41(12):801-4. Zhonghua Nei Ke Za Zhi. 2002. PMID: 12654231 Chinese.

4

[Study of murine hematopoietic stem/progenitor cell mobilized by recombinant human interleukin 11 combination with granulocyte-colony stimulating factor].

Meng FY, Jiang ZJ, Yi ZS, Xu D. Meng FY, et al. Zhonghua Xue Ye Xue Za Zhi. 2003 May;24(5):225-7. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12859869 Chinese.

5

[Experimental study of optimized H-2 haploidentical hematopoietic engraftment for the treatment of murine acute leukemia model].

Meng FY, Lin Y, Xu D, Yang Y, Song LL. Meng FY, et al. Zhonghua Xue Ye Xue Za Zhi. 2003 Apr;24(4):197-9. Zhonghua Xue Ye Xue Za Zhi. 2003. PMID: 12864951 Chinese.

6

[Role of vascular endothelial growth factor (VEGF) in development and progress of refractory acute myeloid leukemia].

Xu D, Meng FY, Yi ZS. Xu D, et al. Among authors: meng fy. Ai Zheng. 2003 Aug;22(8):844-8. Ai Zheng. 2003. PMID: 12917032 Chinese.

7

[Effect of autocrine vascular endothelial growth factor on the biological activity of acute myeloid leukemia cell line HL-60].

Xu D, Meng FY, Liu QF, Yi ZS. Xu D, et al. Among authors: meng fy. Di Yi Jun Yi Da Xue Xue Bao. 2003 Oct;23(10):1050-3. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14559691 Chinese.

8

[Modified FLAG regimen in the management of refractory acute myeloid leukemia].

Yang LJ, Meng FY, Xu B, Liu XL, Zheng WY, Zhang Y, Huang F, Xu D, Sun J, Liu QF. Yang LJ, et al. Among authors: meng fy. Di Yi Jun Yi Da Xue Xue Bao. 2003 Oct;23(10):1054-5. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14559692 Clinical Trial. Chinese.

9

[Quadruple therapy with CsA, MTX, MMF and ATG for preventing graft-versus-host disease in unrelated donor hematopoietic stem cell transplantation].

Liu QF, Sun J, Zhang Y, Xu D, Liu XL, Xu B, Meng FY, Zhou SY. Liu QF, et al. Among authors: meng fy. Di Yi Jun Yi Da Xue Xue Bao. 2003 Nov;23(11):1143-5. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14625172 Chinese.

10

[STI 571 for treating 19 patients with chronic-phase chronic myeloid leukemia].

Meng FY, Zheng WY, Liu XL, Xu B, Song LL, Zhang Y, Huang F. Meng FY, et al. Di Yi Jun Yi Da Xue Xue Bao. 2003 Nov;23(11):1149-50. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 14625174 Chinese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

261 results

Search Page

Filters